Skip to Content
Merck
  • Optimization and validation of an RP-HPLC method for analysis of hydrocortisone acetate and lidocaine in suppositories.

Optimization and validation of an RP-HPLC method for analysis of hydrocortisone acetate and lidocaine in suppositories.

Journal of AOAC International (2010-03-26)
Biljana Jancic-Stojanović, Andjelija Malenović, Slavko Marković, Darko Ivanović, Mirjana Medenica
ABSTRACT

An RP-HPLC method has been optimized and validated for the simultaneous determination of hydrocortisone acetate and of lidocaine in suppositories. For the method optimization, response surface methodology was applied, and the obtained model was tested using analysis of variance. The optimal separations were conducted on a Beckman-Coulter 150 x 4.6 mm, 5 microm particle-size column at 20 degrees C. The mobile phase was methanol-water (65 + 35, v/v), pH adjusted to 2.5 with 85% orthophosphoric acid, with a flow rate of 1.0 ml/min. UV detection was performed at 250 nm. Phenobarbital was used as an internal standard. The method was validated for selectivity, linearity, precision, and robustness.

MATERIALS
Product Number
Brand
Product Description

Hydrocortisone acetate, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Hydrocortisone 21-acetate, ≥98% (HPLC)
Sigma-Aldrich
Hydrocortisone 21-acetate, meets USP testing specifications